User profiles for Pascual Sánchez-Juan

Pascual Sanchez-Juan

Fundación CIEN
Verified email at fundacioncien.es
Cited by 14130

Mortalidad al año en fracturas de cadera y demora quirúrgica

…, MA Alonso-Aguirre, P Sánchez-Juan - Revista Española de …, 2010 - Elsevier
Objetivo Analizar la relación entre el retraso en la cirugía de fractura de cadera por causas
administrativoorganizativas y el índice de mortalidad. Material y método Estudio …

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis

…, A Drzezga, S Forster, T Grimmer, P Sánchez-Juan… - Jama, 2015 - jamanetwork.com
Importance Amyloid-β positron emission tomography (PET) imaging allows in vivo detection
of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its …

Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum

…, O Sabri, J Sakhardande, P Sánchez-Juan… - JAMA …, 2022 - jamanetwork.com
Importance One characteristic histopathological event in Alzheimer disease (AD) is cerebral
amyloid aggregation, which can be detected by biomarkers in cerebrospinal fluid (CSF) and …

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

…, U Rot, CC Rowe, E Rüther, O Sabri, P Sanchez-Juan… - Jama, 2015 - jamanetwork.com
Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

…, R Thomas, JA Brody, L Qu, P Sanchez-Juan… - Nature …, 2017 - nature.com
We identified rare coding variants associated with Alzheimer's disease in a three-stage case–control
study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-…

Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia

…, KS Frederiksen, P SánchezJuan… - Annals of …, 2018 - Wiley Online Library
Objective To estimate the prevalence of amyloid positivity, defined by positron emission
tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, …

Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease

D Alcolea, P Martínez-Lage, P Sánchez-Juan… - Neurology, 2015 - AAN Enterprises
Objective: To investigate CSF markers involved in amyloid precursor protein processing,
neuronal damage, and neuroinflammation in the preclinical stages of Alzheimer disease (AD) …

[HTML][HTML] Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex

…, NA Royle, P Sachdev, P Sánchez-Juan… - Brain imaging and …, 2017 - Springer
The two hemispheres of the human brain differ functionally and structurally. Despite over a
century of research, the extent to which brain asymmetry is influenced by sex, handedness, …

MicroRNA profile in patients with Alzheimer's disease: analysis of miR-9-5p and miR-598 in raw and exosome enriched cerebrospinal fluid samples

…, E Rodríguez, A Lleó, P Sánchez-Juan - Journal of …, 2017 - content.iospress.com
Background: MicroRNAs have been postulated as potential biomarkers for Alzheimer’s
disease (AD). Exosomes are nanovesicles which transport microRNAs, proteins, and other …

Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3–90 years

…, R Salvador, P SánchezJuan - Human brain …, 2022 - Wiley Online Library
Age has a major effect on brain volume. However, the normative studies available are
constrained by small sample sizes, restricted age coverage and significant methodological …